
Gaining provider status is a complex and multifaceted objective.
Baricitinib is a Janus-kinase inhibitor that interferes with intracellular enzymes in rheumatoid arthritis.
Rapamycin may effectively treat patients with venous malformations.
Research identifies important therapeutic target in cancer treatment.
Screening for vitamin D levels vital when treating adolescents with diabetes.
Antiviral drugs can spare livers for patients with other liver diseases.
Top news of the day from across the healthcare landscape.
Top news of the day from across the health care landscape.
Natalizumab has been generally considered among the most effective treatments for relapsing-remitting multiple sclerosis.
Vismodegib and sonidegib reduced advanced basal cell carcinoma tumors in 43% of patients with locally advanced disease.
Compounds derived from a drug previously investigated for the treatment of Ewing sarcoma.
Minimizing sedentary behavior offers potential benefits for people with multiple sclerosis.
TAT-CaM could potentially have a multitude of applications, including cancer treatment.
The cost of oral cancer drugs spiked six-fold within the last 14 years.
Women with proliferating cells within mammary epithelium cells significantly more likely to develop breast cancer.
A large portion of patients who received experimental drug had their tumors stop growing.
Incretin-based drugs help type 2 diabetes patients reduce blood sugar.
Ability to produce epiregulin may influence cancer development.
Tops news of the day from across the healthcare landscape.
Skyrocketing prescription drug prices sit squarely at the center of policy debates about the US health care system.
Study evaluates whether smoking cigarettes worsens clinical damage in PsA patients as it does in rheumatoid arthritis and ankylosing spondylitis.
Raltegravir may help boost adherence and help prevent vaginal HIV transmission.
Patients with colorectal, breast, or prostate cancers taking low-dose aspirin along with chemotherapy are shown to have better survival rates.
Pathologists revised the terminology of a type of thyroid tumor to remove “cancer†from its name.
Top news of the day from across the healthcare landscape.
Radiation therapy plus chemotherapy extends overall survival in patients with grade 2 glioma.
Researchers seek to reverse lung injury caused by cancer treatments.
A commonly held axiom in specialty pharmacy is that the patient is at the center of every action.
In 2015, specialty medications accounted for 37.7% of total drug spending.
Obese people found to be at greater risk for developing colon cancer.